0000905718-14-000496.txt : 20140807 0000905718-14-000496.hdr.sgml : 20140807 20140807122639 ACCESSION NUMBER: 0000905718-14-000496 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140807 DATE AS OF CHANGE: 20140807 EFFECTIVENESS DATE: 20140807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Scilex Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001603542 IRS NUMBER: 800861274 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-222461 FILM NUMBER: 141022684 BUSINESS ADDRESS: STREET 1: 101 LINDENWOOD DR. STREET 2: SUITE 225 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 949-413-2672 MAIL ADDRESS: STREET 1: 101 LINDENWOOD DR. STREET 2: SUITE 225 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Scilex Pharmaceuticals, Inc DATE OF NAME CHANGE: 20140325 D 1 primary_doc.xml X0707 D LIVE 0001603542 Scilex Pharmaceuticals Inc. 101 LINDENWOOD DR. SUITE 225 MALVERN PA PENNSYLVANIA 19355 949-413-2672 DELAWARE None Scilex Pharmaceuticals, Inc Corporation true 2012 William Pedranti 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Anthony P. Mack 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Eric Floyd 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Director Jerrold B. Sendrow 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Director Richard Cohen 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Executive Officer Pharmaceuticals Decline to Disclose 06b false true false true true false 0 5001700 0 5001700 Offer being made to certain existing security holders pursuant to rescission offer. false 0 0 0 0 false Scilex Pharmaceuticals Inc. /s/ Anthony Mack Anthony Mack Chief Executive Officer and President 2014-08-07